Korean J Pain.  2020 Jul;33(3):208-215. 10.3344/kjp.2020.33.3.208.

Zoster sine herpete: a review

• Zhou J
• Li J
• Ma L
• Cao S

• KMID: 2504066
• DOI: http://doi.org/10.3344/kjp.2020.33.3.208

Abstract

Zoster sine herpete (ZSH) is one of the atypical clinical manifestations of herpes zoster (HZ), which stems from infection and reactivation of the varicella-zoster virus (VZV) in the cranial nerve, spinal nerve, viscera, or autonomic nerve. Patients with ZSH display variable symptoms, such as neuralgia, however, different from HZ, ZSH show no zoster, which makes clinical diagnosis difficult. ZSH not only causes initial symptoms, such as neuropathic pain in the affected nerve, Bell palsy, and Ramsay Hunt syndrome, but also postherpetic neuralgia and fatal complications such as VZV encephalitis and stroke. The misdiagnosis of ZSH and tardy antiviral treatment may lead to severe ZSH sequelae. We review the publications related to ZSH, especially its diagnosis with VZV DNA and/or anti-VZV immunoglobulin (IgG and IgM). More work about ZSH, especially ZSH epidemiological survey and guidelines for its diagnosis and treatment, are needed because most of the present studies are case reports.

Keyword

Antiviral Agents; Diagnosis; Herpes Zoster; Herpesvirus 3, Human; Infections; Neuralgia, Postherpetic; Therapeutics; Virus Diseases; Zoster Sine Herpete

Reference

1. Dayan RR, Peleg R. 2017; Herpes zoster - typical and atypical presentations. Postgrad Med. 129:567–71. DOI: 10.1080/00325481.2017.1335574. PMID: 28540752.

2. Nagel MA, Gilden DH. 2007; The protean neurologic manifestations of varicella-zoster virus infection. Cleve Clin J Med. 74:489–94. 496498–9 passim. DOI: 10.3949/ccjm.74.7.489. PMID: 17682626.

3. Kennedy PGE, Gershon AA. 2018; Clinical features of varicella-zoster virus infection. Viruses. 10:609. DOI: 10.3390/v10110609. PMID: 30400213. PMCID: PMC6266119.

4. Jeon YH. 2015; Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment. Korean J Pain. 28:177–84. DOI: 10.3344/kjp.2015.28.3.177. PMID: 26175877. PMCID: PMC4500781.

5. Lewis GW. 1958; Zoster sine herpete. Br Med J. 2:418–21. DOI: 10.1136/bmj.2.5093.418. PMID: 13560886. PMCID: PMC2026052.

6. Drago F, Herzum A, Ciccarese G, Broccolo F, Rebora A, Parodi A. 2019; Acute pain and postherpetic neuralgia related to varicella zoster virus reactivation: comparison between typical herpes zoster and zoster sine herpete. J Med Virol. 91:287–95. DOI: 10.1002/jmv.25304. PMID: 30179265.

7. Ibraheem M, Marin M, Leung J, Bryce CH, Schmid DS, Zaki SR, et al. 2013; Fatal wild-type varicella-zoster virus encephalitis without a rash in a vaccinated child. Pediatr Infect Dis J. 32:183–5. DOI: 10.1097/INF.0b013e318273e43d. PMID: 22982982.

8. Chen WH, Chui C, Yin HL. 2013; Zoster sine herpete, vertebral artery stenosis, and ischemic stroke. J Stroke Cerebrovasc Dis. 22:e234–7. DOI: 10.1016/j.jstrokecerebrovasdis.2012.07.017. PMID: 22974704.

9. Weaver BA. 2009; Herpes zoster overview: natural history and incidence. J Am Osteopath Assoc. 109(6 Suppl 2):S2–6. PMID: 19553632.

10. Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, et al. 2015; Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: the SHEZ study. J Epidemiol. 25:617–25. DOI: 10.2188/jea.JE20140210. PMID: 26399445. PMCID: PMC4626391.

11. Yang F, Yu S, Fan B, Liu Y, Chen YX, Kudel I, et al. 2019; The epidemiology of herpes zoster and postherpetic neuralgia in China: results from a cross-sectional study. Pain Ther. 8:249–59. DOI: 10.1007/s40122-019-0127-z. PMID: 31218562. PMCID: PMC6857181.

12. Tseng HF, Bruxvoort K, Ackerson B, Luo Y, Tanenbaum H, Tian Y, et al. 2019; The epidemiology of herpes zoster in immunocompetent, unvaccinated adults ≥50 years old: incidence, complications, hospitalization, mortality, and recurrence. J Infect Dis. doi: 10.1093/infdis/jiz652. DOI: 10.1093/infdis/jiz652. PMID: 31830250.

13. Johnson RW, Rice AS. 2014; Clinical practice. Postherpetic neuralgia. N Engl J Med. 371:1526–33. DOI: 10.1056/NEJMcp1403062. PMID: 25317872.

14. Kawai K, Gebremeskel BG, Acosta CJ. 2014; Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 4:e004833. DOI: 10.1136/bmjopen-2014-004833. PMID: 24916088. PMCID: PMC4067812.

15. Kawai K, Yawn BP, Wollan P, Harpaz R. 2016; Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 63:221–6. DOI: 10.1093/cid/ciw296. PMID: 27161774. PMCID: PMC4928389.

16. Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. 2010; Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. 48(Suppl 1):S2–7. DOI: 10.1016/S1386-6532(10)70002-0.

17. Koshy E, Mengting L, Kumar H, Jianbo W. 2018; Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Indian J Dermatol Venereol Leprol. 84:251–62. DOI: 10.4103/ijdvl.ijdvl_1021_16. PMID: 29516900.

18. Sauerbrei A. 2016; Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections. Eur J Clin Microbiol Infect Dis. 35:723–34. DOI: 10.1007/s10096-016-2605-0. PMID: 26873382.

19. Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. 2015; Varicella zoster virus infection. Nat Rev Dis Primers. 1:15016. DOI: 10.1038/nrdp.2015.16. PMID: 27188665. PMCID: PMC5381807.

20. McDonald JR, Zeringue AL, Caplan L, Ranganathan P, Xian H, Burroughs TE, et al. 2009; Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis. 48:1364–71. DOI: 10.1086/598331. PMID: 19368499. PMCID: PMC2743911.

21. Laemmle L, Goldstein RS, Kinchington PR. 2019; Modeling varicella zoster virus persistence and reactivation - closer to resolving a perplexing persistent state. Front Microbiol. 10:1634. DOI: 10.3389/fmicb.2019.01634. PMID: 31396173. PMCID: PMC6667558.

22. Arvin A. 2005; Aging, immunity, and the varicella-zoster virus. N Engl J Med. 352:2266–7. DOI: 10.1056/NEJMp058091. PMID: 15930416.

23. Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW. 2005; Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol. 79:12658–66. DOI: 10.1128/JVI.79.20.12658-12666.2005. PMID: 16188968. PMCID: PMC1235827.

24. Hevner R, Vilela M, Rostomily R, Cohrs R, Mahalingam R, Wellish M, et al. 2003; An unusual cause of trigeminal-distribution pain and tumour. Lancet Neurol. 2:567–71. DOI: 10.1016/S1474-4422(03)00506-4. PMID: 12941580.

25. Birlea M, Nagel MA, Khmeleva N, Choe A, Kleinschmidt-Demasters B, Hevner R, et al. 2014; Varicella-zoster virus trigeminal ganglioneuritis without rash. Neurology. 82:90–2. DOI: 10.1212/01.wnl.0000438228.48470.86. PMID: 24285619. PMCID: PMC3873618.

26. Zerboni L, Arvin A. 2015; Neuronal subtype and satellite cell tropism are determinants of varicella-zoster virus virulence in human dorsal root ganglia xenografts in vivo. PLoS Pathog. 11:e1004989. DOI: 10.1371/journal.ppat.1004989. PMID: 26090802. PMCID: PMC4474629.

27. Furuta Y, Fukuda S, Suzuki S, Takasu T, Inuyama Y, Nagashima K. 1997; Detection of varicella-zoster virus DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete. J Med Virol. 52:316–9. DOI: 10.1002/(SICI)1096-9071(199707)52:3<316::AID-JMV13>3.0.CO;2-G.

28. Gershon AA, Gershon MD. 2016; The Jeremiah Metzger lecture varicella zoster virus: from outside to inside. Trans Am Clin Climatol Assoc. 127:282–99. DOI: 10.1128/9781555819439.ch22. PMID: 28066065. PMCID: PMC5216500.

29. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. 2010; Neurological disease produced by varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol. 342:243–53. DOI: 10.1007/82_2009_3. PMID: 20186614. PMCID: PMC3076592.

30. Galetta KM, Gilden D. 2015; Zeroing in on zoster: a tale of many disorders produced by one virus. J Neurol Sci. 358:38–45. DOI: 10.1016/j.jns.2015.10.004. PMID: 26454371. PMCID: PMC4628852.

31. Kennedy PG. 2011; Zoster sine herpete: it would be rash to ignore it. Neurology. 76:416–7. DOI: 10.1212/WNL.0b013e31820a0d5d. PMID: 21282588.

32. Edelman DA, Antaki F, Basson MD, Salwen WA, Gruber SA, Losanoff JE. 2010; Ogilvie syndrome and herpes zoster: case report and review of the literature. J Emerg Med. 39:696–700. DOI: 10.1016/j.jemermed.2009.02.010. PMID: 19327938.

33. Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. 1994; Zoster sine herpete, a clinical variant. Ann Neurol. 35:530–3. DOI: 10.1002/ana.410350505. PMID: 8179298.

34. Kasahara M, Ichinohe T, Sano T, Fukuda K, Kaneko Y. 2011; A case of zoster sine herpete of the trigeminal nerve. Bull Tokyo Dent Coll. 52:47–51. DOI: 10.2209/tdcpublication.52.47. PMID: 21467781.

35. Hosseini S, Zawawi F, Young J. 2015; Atypical presentation of a common disease: shingles of the larynx. J Voice. 29:600–2. DOI: 10.1016/j.jvoice.2014.10.010. PMID: 25873549.

36. Sengoku R, Yaguchi H, Matsushima S, Mochio S. 2012; Zoster sine herpete: detection by skin exudates and contrast magnetic resonance imaging. Eur Neurol. 67:154. DOI: 10.1159/000334924. PMID: 22261654.

37. Silverstein BE, Chandler D, Neger R, Margolis TP. 1997; Disciform keratitis: a case of herpes zoster sine herpete. Am J Ophthalmol. 123:254–5. DOI: 10.1016/S0002-9394(14)71044-X. PMID: 9186133.

38. Gershon AA, Chen J, Gershon MD. 2015; Use of saliva to identify varicella zoster virus infection of the gut. Clin Infect Dis. 61:536–44. DOI: 10.1093/cid/civ320. PMID: 25882301. PMCID: PMC4607733.

39. Gershon AA, Gershon MD. 2013; Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev. 26:728–43. DOI: 10.1128/CMR.00052-13. PMID: 24092852. PMCID: PMC3811230.

40. Leung J, Harpaz R, Baughman AL, Heath K, Loparev V, Vázquez M, et al. 2010; Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis. 51:23–32. DOI: 10.1086/653113. PMID: 20504232.

41. Quinlivan M, Sengupta N, Papaevangelou V, Sauerbrei A, Grillner L, Rousseva R, et al. 2013; Use of oral fluid to examine the molecular epidemiology of varicella zoster virus in the United Kingdom and continental Europe. J Infect Dis. 207:588–93. DOI: 10.1093/infdis/jis649. PMID: 23087434. PMCID: PMC3549596.

42. Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS. 2011; Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis. 203:316–23. DOI: 10.1093/infdis/jiq066. PMID: 21177308. PMCID: PMC3071104.

43. Papaevangelou V, Quinlivan M, Lockwood J, Papaloukas O, Sideri G, Critselis E, et al. 2013; Subclinical VZV reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration. Clin Microbiol Infect. 19:E245–51. DOI: 10.1111/1469-0691.12131. PMID: 23331898.

44. Tecellioglu M, Kamisli S, Erbay MF, Kamisli O, Ozcan C. 2017; A rare presentation of cranial polyneuropathy without rash caused by varicella zoster virus. Med Arch. 71:293–5. DOI: 10.5455/medarh.2017.71.293-295. PMID: 28974853. PMCID: PMC5585840.

45. Gershon AA. 2011; The history and mystery of VZV in saliva. J Infect Dis. 204:815–6. DOI: 10.1093/infdis/jir417. PMID: 21849276. PMCID: PMC3156916.

46. Park SY, Kim JY, Kwon JS, Jeon NY, Kim MC, Chong YP, et al. 2019; Relationships of varicella zoster virus (VZV)-specific cell-mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster. J Med Virol. 91:1995–2000. DOI: 10.1002/jmv.25543. PMID: 31286531.

47. Nahass GT, Penneys NS, Leonardi CL. 1992; The clinical spectrum from classic varicella zoster to zoster sine herpete: the missing link. Arch Dermatol. 128:1278–9. DOI: 10.1001/archderm.1992.01680190138027. PMID: 1519950.

48. Easton HG. 1970; Zoster sine herpete causing acute trigeminal neuralgia. Lancet. 2:1065–6. DOI: 10.1016/S0140-6736(70)90291-6. PMID: 4098355.

49. Nagel MA, Gilden D. 2014; Neurological complications of varicella zoster virus reactivation. Curr Opin Neurol. 27:356–60. DOI: 10.1097/WCO.0000000000000092. PMID: 24792344. PMCID: PMC4189810.

50. Vena GA, Apruzzi D, Vestita M, Calvario A, Foti C, Cassano N. 2010; Zoster ... “almost” ... sine herpete: diagnostic utility of real time-polymerase chain reaction. New Microbiol. 33:409–10.

51. Lee HY, Kim MG, Park DC, Park MS, Byun JY, Yeo SG. 2012; Zoster sine herpete causing facial palsy. Am J Otolaryngol. 33:565–71. DOI: 10.1016/j.amjoto.2012.02.001. PMID: 22445107.

52. Furuta Y, Ohtani F, Mesuda Y, Fukuda S, Inuyama Y. 2000; Early diagnosis of zoster sine herpete and antiviral therapy for the treatment of facial palsy. Neurology. 55:708–10. DOI: 10.1212/WNL.55.5.708. PMID: 10980741.

53. Tamir B, Peleg R. 2015; Burning pain from chest to backㆍallodynia and hyperesthesiaㆍextreme sensitivity at the left T5 dermatomeㆍDx? J Fam Pract. 64:E1–2.

54. Morita Y, Osaki Y, Doi Y, Forghani B, Gilden DH. 2003; Chronic active VZV infection manifesting as zoster sine herpete, zoster paresis and myelopathy. J Neurol Sci. 212:7–9. DOI: 10.1016/S0022-510X(03)00081-9. PMID: 12809993.

55. Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, et al. 2007; The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology. 68:1069–73. DOI: 10.1212/01.wnl.0000258549.13334.16. PMID: 17287447.

56. Haug A, Mahalingam R, Cohrs RJ, Schmid DS, Corboy JR, Gilden D. 2010; Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: case report and review of the literature. J Neurol Sci. 292:85–8. DOI: 10.1016/j.jns.2010.01.019. PMID: 20170926. PMCID: PMC2846975.

57. Gilden D, Nagel MA, Ransohoff RM, Cohrs RJ, Mahalingam R, Tanabe JL. 2009; Recurrent varicella zoster virus myelopathy. J Neurol Sci. 276:196–8. DOI: 10.1016/j.jns.2008.09.025. PMID: 18945446. PMCID: PMC2828365.

58. Blumenthal DT, Shacham-Shmueli E, Bokstein F, Schmid DS, Cohrs RJ, Nagel MA, et al. 2011; Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF. Neurology. 76:484–5. DOI: 10.1212/WNL.0b013e31820a0d28. PMID: 21282595. PMCID: PMC3034410.

59. Amlie-Lefond C, Mackin GA, Ferguson M, Wright RR, Mahalingam R, Gilden DH. 1996; Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol. 2:136–8. DOI: 10.3109/13550289609146547. PMID: 8799205.

60. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. 2000; Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 342:635–45. DOI: 10.1056/NEJM200003023420906. PMID: 10699164.

61. Pollak L, Mehta SK, Pierson DL, Sacagiu T, Avneri Kalmanovich S, Cohrs RJ. 2015; Varicella-zoster DNA in saliva of patients with meningoencephalitis: a preliminary study. Acta Neurol Scand. 131:417–21. DOI: 10.1111/ane.12335. PMID: 25314141.

62. Yamada S, Atsuta N, Tokunaga S, Motegi Y. 2003; Ipsilateral truncal sensory deficit in a patient with ophthalmic zoster sine herpete. Neurology. 60:1049–50. DOI: 10.1212/01.WNL.0000052999.43687.7B. PMID: 12654984.

63. Mantero V, De Toni Franceschini L, Lillia N, Guccione A, Santilli I, Agostoni E. 2013; Varicella-zoster meningoencephaloradiculoneuropathy in an immunocompetent young woman. J Clin Virol. 57:361–2. DOI: 10.1016/j.jcv.2013.04.006. PMID: 23778237.

64. Spagnoli C, Cantalupo G, Piccolo B, Cerasti D, Pisani F. 2013; Unusual trigeminal autonomic pain heralding hemichorea due to zoster sine Herpete vasculopathy. Pediatr Neurol. 49:205–8. DOI: 10.1016/j.pediatrneurol.2013.04.003. PMID: 23838411.

65. Persson A, Bergström T, Lindh M, Namvar L, Studahl M. 2009; Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol. 46:249–53. DOI: 10.1016/j.jcv.2009.07.014. PMID: 19709927.

66. Dueland AN, Devlin M, Martin JR, Mahalingam R, Cohrs R, Manz H, et al. 1991; Fatal varicella-zoster virus meningoradiculitis without skin involvement. Ann Neurol. 29:569–72. DOI: 10.1002/ana.410290520. PMID: 1650163.

67. Kleinschmidt-DeMasters BK, Gilden DH. 2001; Varicella-zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med. 125:770–80.

68. Philip A, Thakur R. 2011; Post herpetic neuralgia. J Palliat Med. 14:765–73. DOI: 10.1089/jpm.2011.9685. PMID: 21651364.

69. Hadley GR, Gayle JA, Ripoll J, Jones MR, Argoff CE, Kaye RJ, et al. 2016; Post-herpetic neuralgia: a review. Curr Pain Headache Rep. 20:17. DOI: 10.1007/s11916-016-0548-x. PMID: 26879875.

70. Harpaz R, Ortega-Sanchez IR, Seward JF. 2008; Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 57:1–30.

71. Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, et al. 2018; Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 67:103–8. DOI: 10.15585/mmwr.mm6703a5. PMID: 29370152. PMCID: PMC5812314.

72. Harpaz R, Leung JW. 2019; The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults. Clin Infect Dis. 69:341–4. DOI: 10.1093/cid/ciy953. PMID: 30496358.

73. Gan EY, Tian EA, Tey HL. 2013; Management of herpes zoster and post-herpetic neuralgia. Am J Clin Dermatol. 14:77–85. DOI: 10.1007/s40257-013-0011-2. PMID: 23456596.

74. Hui F, Boyle E, Vayda E, Glazier RH. 2012; A randomized controlled trial of a multifaceted integrated complementary-alternative therapy for chronic herpes zoster-related pain. Altern Med Rev. 17:57–68. PMID: 22502623.

75. Abdel-Aziz M, Azab NA, Khalifa B, Rashed M, Naguib N. 2015; The association of Varicella zoster virus reactivation with Bell’s palsy in children. Int J Pediatr Otorhinolaryngol. 79:328–31. DOI: 10.1016/j.ijporl.2014.12.010. PMID: 25599860.

76. Argoff CE. 2011; Review of current guidelines on the care of postherpetic neuralgia. Postgrad Med. 123:134–42. DOI: 10.3810/pgm.2011.09.2469. PMID: 21904096.

77. Schlereth T, Heiland A, Breimhorst M, Féchir M, Kern U, Magerl W, et al. 2015; Association between pain, central sensitization and anxiety in postherpetic neuralgia. Eur J Pain. 19:193–201. DOI: 10.1002/ejp.537. PMID: 25070366.

78. McCarberg B. 2003; Managing the comorbidities of postherpetic neuralgia. J Am Acad Nurse Pract. 15(12 Suppl):16–21.

79. Cao S, Li Y, Deng W, Qin B, Zhang Y, Xie P, et al. 2017; Local brain activity differences between herpes zoster and postherpetic neuralgia patients: a resting-state functional MRI study. Pain Physician. 20:E687–99. PMID: 28727713.

80. Cao S, Qin B, Zhang Y, Yuan J, Fu B, Xie P, et al. 2018; Herpes zoster chronification to postherpetic neuralgia induces brain activity and grey matter volume change. Am J Transl Res. 10:184–99. PMID: 29423004. PMCID: PMC5801357.

81. Cao S, Song G, Zhang Y, Xie P, Tu Y, Li Y, et al. 2017; Abnormal local brain activity beyond the pain matrix in postherpetic neuralgia patients: a resting-state functional MRI study. Pain Physician. 20:E303–14. DOI: 10.36076/ppj.2017.E314.